Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Asia Pacific Wire & Cable
APWC
$66M
| $91K | ﹤0.01% |
72,400
-600
| -0.8% | -$795 |
|
3327
One Stop Systems
OSS
$332M
| $91K | ﹤0.01% |
43,200
+4,700
| +12% | +$9.45K |
|
3328
Exagen
XGN
$160M
| $91K | ﹤0.01% |
+45,488
| New | +$78.7K |
|
3329
Biodesix
BDSX
$233M
| $90K | ﹤0.01% |
2,440
+1,370
| +128% | +$43K |
|
|
ASLN
3330
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $90K | ﹤0.01% |
21,600
+17,417
| +416% | +$131K |
|
3331
Elutia
ELUT
$38.9M
| $89K | ﹤0.01% |
41,177
+11,661
| +40% | +$19.1K |
|
3332
Vertical Aerospace
EVTL
$160M
| $89K | ﹤0.01% |
+12,987
| New | +$115K |
|
|
MYND
3333
Mynd.ai
MYND
$19.2M
| $89K | ﹤0.01% |
+16,044
| New | +$147K |
|
3334
FreightCar America
RAIL
$253M
| $89K | ﹤0.01% |
+32,800
| New | +$82.8K |
|
|
AIM
3335
AIM ImmunoTech
AIM
$7.51M
| $89K | ﹤0.01% |
2,022
+97
| +5% | +$4.52K |
|
3336
Recon Technology
RCON
$3.8M
| $88K | ﹤0.01% |
20,874
-14,332
| -41% | -$70.6K |
|
|
MTEM
3337
DELISTED
Molecular Templates, Inc.
MTEM
| $88K | ﹤0.01% |
23,653
+7,895
| +50% | +$41.3K |
|
3338
Arts-Way Manufacturing Co
ARTW
$11.1M
| $87K | ﹤0.01% |
42,174
-14,500
| -26% | -$30K |
|
3339
Oragenics
OGEN
$2.45M
| $87K | ﹤0.01% |
514
+63
| +14% | +$7.46K |
|
3340
Laird Superfood
LSF
$50M
| $86K | ﹤0.01% |
94,100
+1,900
| +2% | +$1.7K |
|
|
CONN
3341
DELISTED
Conn's Inc.
CONN
| $86K | ﹤0.01% |
19,312
+4,900
| +34% | +$16.2K |
|
|
EZGO
3342
EZGO Technologies
EZGO
$2.31M
| $85K | ﹤0.01% |
+5
| New | +$82.2K |
|
|
NUTX
3343
Nutex Health
NUTX
$1.05B
| $85K | ﹤0.01% |
3,145
+2,986
| +1,878% | +$93.1K |
|
3344
Universal Safety Products Inc
UUU
$10.8M
| $85K | ﹤0.01% |
+51,185
| New | +$143K |
|
|
RNTX
3345
Rein Therapeutics
RNTX
$67.4M
| $85K | ﹤0.01% |
28,019
+9,055
| +48% | +$17.7K |
|
3346
American Shared Hospital Services
AMS
$9.67M
| $84K | ﹤0.01% |
35,500
-24,488
| -41% | -$58.9K |
|
|
FNCB
3347
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $84K | ﹤0.01% |
12,300
-426
| -3% | -$2.6K |
|
|
NURO
3348
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $84K | ﹤0.01% |
23,432
+19,674
| +524% | +$82.7K |
|
3349
Genprex
GNPX
$2.24M
| $83K | ﹤0.01% |
+8
| New | +$92.3K |
|
3350
POET Technologies
POET
$1.47B
| $83K | ﹤0.01% |
+88,700
| New | +$155K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.